Cargando…
IDH Mutation Analysis in Glioma Patients by CADMA Compared with SNaPshot Assay and two Immunohistochemical Methods
Mutations in IDH1/2 genes are a marker of good prognosis for glioma patients, associated with low grade gliomas and secondary glioblastomas. Immunohistochemistry and Sanger sequencing are current standards for IDH1/2 genotyping while many other methods exist. The aim of this study was to validate Co...
Autores principales: | Urbanovska, Irena, Megova, Magdalena Houdova, Dwight, Zachary, Kalita, Ondrej, Uvirova, Magdalena, Simova, Jarmila, Tuckova, Lucie, Buzrla, Petr, Palecek, Tomas, Hajduch, Marian, Dvorackova, Jana, Drabek, Jiri |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6614140/ https://www.ncbi.nlm.nih.gov/pubmed/29556922 http://dx.doi.org/10.1007/s12253-018-0413-9 |
Ejemplares similares
-
SNaPshot as a Valuable Option for the Identification of Mutations in Myeloma
por: Moreaux, Jerome
Publicado: (2014) -
Identification of horse chestnut coat color genotype using SNaPshot(®)
por: Rendo, Fernando, et al.
Publicado: (2009) -
Clinical Grade “SNaPshot” Genetic Mutation Profiling in Multiple Myeloma
por: O'Donnell, Elizabeth, et al.
Publicado: (2014) -
Comparison of methods for pharmacogenomics: SNaPshot, SNPstream UHT, Nanogen, and RFLP
por: Alnæs, GIG, et al.
Publicado: (2005) -
IDH1/2 Mutations in Patients With Diffuse Gliomas: A Single Centre Retrospective Massively Parallel Sequencing Analysis
por: Sporikova, Zuzana, et al.
Publicado: (2022)